The Texas Society of Pathologists is active year-round monitoring important legislative and economic issues that impact our members. The Economic Affairs Committee and the Legislative Council are action-based and results driven to support positive outcomes for pathologists across the state. TSP leadership maintains active communication with the TSP’s lobbyist on important issues and maintains a presence within various Texas Medical Association committees for additional advocacy support.  Additionally, relationships with national organizations, such as the College of American Pathologists (CAP) and the American Society for Clinical Pathology (ASCP) serve as invaluable resources to the TSP on numerous legislative and economic focuses throughout the year.

The TSP needs your support to continue impacting positive change for our members and for the profession of pathology! 

Not sure of who your representatives are? These sites will assist you!

Texas House of Representatives

United States House of Representatives
   

CPT 88305 Under CMS Review: What Pathologists Need to Know | TSP-CAP Advocacy Webinar

CMS is asking for public comment on whether the surgical pathology code family (CPT 88330-88309), including 88305 and 88307, is "potentially misvalued." It could act as early was 2027. In this joint Texas Society of Pathologists (TSP) and College of American Pathologists (CAP) webinar, Dr. A. Joe Saad explains where the review came from, why CAP says the data falls short, and what pathologists can do before the comment period closes. 

TAKE ACTION: The public comment period closes September 14, 2026. CAP's action alert includes pre-written comments you can edit or send as-is. It takes less than a minute: https://cap.action.aristotle.com/alert/105a499f-ecf6-40db-82ad-4f7544f2b653

IN THIS WEBINAR:
  • How the CY 2027 proposed Medicare Physician Fee Schedule flagged the 88305 code family
  • The Maryland Health Care Commission's claims-data analysis, and why CAP says it isn't representative, transparent or validated. 
  • Why empirical data can't yet replace the AMA RUC physician survey process
  • CAP's ask: no unilateral changes for 2027. Revalue the codes through the CPT/RUC process.
  • State advocacy updates, including Virginia's first-in-the-nation ban on pathology in-network steering and joint TSP-CAP work in Texas.
  • A member Q&A on 88305 heterogeneity, how CMS handles comments, and pressure on RUC

Recorded on September 10, 2026.

   

Previous Advocacy Updates